InnovationRx is your weekly digest of healthcare news. Sign up!
Microsoft Wants To Automate Medical Notes With GPT-4— But Doctors Need Convincing
ILLUSTRATION BY YUNJIA YUAN FOR FORBES; GETTY IMAGES/DNY59; GETTY IMAGES/SUBJUG; GETTY IMAGES/NENOV; GETTY IMAGES/THAMRONGPAT THEERATHAMMAKORN An app called the Dragon Ambient eXperience, or DAX, records doctor’s interactions with patients and uses artificial intelligence to generate notes for the medical record. It was developed by Nuance Communications, Microsoft’s $19 billion bet on the future of AI in healthcare. So far there has been a human quality reviewer checking the AI’s work before it's sent to the doctor for a final review.
in Kindbody. The startup, which has raised $315 million, operates 32 fertility clinics and offers reproductive health benefits for large employers, including Walmart and Medtronic.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
InnovationRx: The FDA OKs The First RSV Vaccine; Microsoft’s AI Play For DoctorsInnovationRx: The FDA OKs The First RSV Vaccine; Microsoft’s AI Play For Doctors by TheAlexKnapp, katiedjennings
Lire la suite »
The Newest FDA-Approved Neuromodulator Will Get Rid of 11-Lines for Six MonthsThis new Botox alternative promises results that last twice as long as its competitors. So—what do actual dermatologists think?
Lire la suite »
Xelstrym to Launch Soon: New FDA-Approved ADHD Stimulant PatchXelstrym is the first FDA-approved transdermal amphetamine patch to treat pediatric and adult patients with ADHD. It is expected to launch later this year.
Lire la suite »
FDA OKs Once-Nightly Sodium Oxybate for NarcolepsyExtended-release sodium oxybate (Lumryz) is taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy.
Lire la suite »
FDA Fast Tracks Potential CAR T-Cell Therapy for LupusThe cellular therapy depletes CD19-positive B cells with the goal of 'resetting' the immune system to achieve durable remission.
Lire la suite »
FDA Does Not Require Menstrual Product Ingredients on LabelsNew York and California have passed laws requiring disclosure of ingredients on menstrual product packaging. Advocates want more transparency across the United States.
Lire la suite »